OCT 07, 2024
Program At-a-glance
|
|||
| DAY 1 Oct 07, 2024 |
|||
| Keynote Session | |||
| 09:00- 09:30 | Cell Culture Process Scale-Up Challenges for Commercial-Scale Manufacturing of Allogeneic Pluripotent Stem Cell Products | ||
| Brian Lee, CEO, PBS Biotech, Inc., USA | |||
| 09:30- 10:00 | Slot Available | ||
| 10:00-10:30 | Animal Regeneration has an evolutionary explanation: a hypothesis | ||
| Lorenzo Alibardi, University of Bologna, Italy | |||
| 10:30- 10: 50 Refreshment Break @ Foyer | |||
| 10:50-11:10 | Senescence-Targeted Intervention and its Impact on Obesity- and Age-Related Liver Disease Progression | ||
| Robert Kass, Columbia University, USA | |||
| 11:10-11:30 | Intercellular communication between neural progenitor cells and the neurovascular unit: modulation by amyloid beta and HIV-1 | ||
| Michal Toborek, University of Miami, USA | |||
| 11:30-11:50 | Xenogeneic-free platform for the isolation and scalable expansion of human bladder smooth muscle cells | ||
| Cláudia Lobato da Silva, Instituto Superior Técnico, Universidade de Lisboa, Portugal | |||
| 11:50-12:10 | From Concepts to Clinic: Engineering of Allogeneic Donor Cells for Acceptance by the Host's Immune System | ||
| Sonja Schrepfer, UCSF & Scientific Founder and SVP of Sana Biotechnology, Inc. | |||
| 12:10-12:30 | Infection-experienced HSPCs provide heterologous protection to subsequent infections by generating neutrophils with enhanced mitochondrial bactericidal activity | ||
| Christopher J. Hall, University of Auckland, New Zealand | |||
| 12:30-12:50 | Production of cell therapeutics: Adherent platforms for expanding human induced pluripotent stem cells | ||
| Misha Teale , Zurich University of Applied Sciences, Switzerland & Marcos F. Q. Sousa, Bayer AG, Germany |
|||
| 12:50-13:10 | A series of studies on hUCB-MNCs therapy for multiple system atrophy | ||
| Dianrong Gong, Liaocheng People's Hospital, China | |||
| 13:10- 14:00 Lunch @ Restaurant | |||
| 14:00-14:20 | Characterization of Bone Marrow Niche in Patients with Chronic Myeloid Leukemia Identifies CXCL14 as a New Therapeutic Option | ||
| Hong Qian, Karolinska Institute, Sweden | |||
| 14:20-14:40 | Cardiac Organoids to Model and Heal Heart Failure and Cardiomyopathies | ||
| Hulot Jean-Sabastien, Université Paris Cité, INSERM, France | |||
| 14:40-15:00 | iPSC-derived reactive astrocytes from patients with multiple sclerosis protect cocultured neurons in inflammatory conditions | ||
| Marlen Alisch, Charité - Universitätsmedizin Berlin and Max Delbrück Center, Germany | |||
| 15:00-15:20 | Aqp2+ progenitor cells maintain and repair distal renal segments | ||
| Wenzheng Zhang, Albany Medical College, USA | |||
| 15:20-15:40 | Using Induced Pluripotent Stem Cells and Kidney Organoids to Model Rare Human Kidney Disease and Find Alternative Treatments | ||
| Jennifer Hollywood, University College Cork, Ireland | |||
| 15:40- 16:00 Refreshment Break @ Foyer | |||
| 16:00-16:20 | Stem and stromal cell factors in prostate cancer differentiation | ||
| Alvin Y. Liu, University of Washington, USA | |||
| 16:20-16:40 | Human embryonic stem cells as a model of HIV drug toxicity in the context of pregnancy | ||
| Helene C.F. Cote, University of British Columbia, Canada | |||
| 16:40-17:00 | Autophagy exerts a protective role in cervical spinal injury by microglia inhibition through the nuclear factor kappa-b pathway | ||
| Yang Xinming, The First Affiliated Hospital of Hebei North University, China | |||
| 17:00-17:20 | Evaluation of the Effects of Human Dental Pulp Stem Cells on the Biological Phenotype of Hypertrophic Keloid Fibroblasts | ||
| Lingling Fu, Guizhou University, China | |||
| 17:20-17:40 | Slot Available | ||
| Day-1 Concludes | |||
09:00-17:00
Day-2 HALL- A
| SCRM-2024 -Scientific Program (***This is a tentative Program and it may undergo periodic changes in the future) |
|
| DAY 2 Oct 08, 2024 HALL- A |
|
| Keynote Session | |
| 09:00- 09:30 | Cardiac Cell Therapy : Hype or Hope ? |
| Philippe Hénon, Founder and Chairman of the Board Scientific Advisor, cellprothera, France | |
| 09:30- 10:00 | Diagnostic Criteria for Traumatic Encephalopathy Syndrome (TES) |
| Barry Jordan, Rancho Los Amigos National Rehabilitation Center, USA | |
| 10:00-10:30 | Slot Available |
| 10:30- 10: 50 Refreshment Break @ Foyer | |
| 10:50-11:10 | Reviewing the State of the Art of Pluripotent Stem Cells for Spinal Cord Injury Repair |
| María Martín López, Andalusian Network for the Design and Translation of Advanced Therapies (And&tAT), Spain | |
| 11:10-11:30 | Extracellular matrix modulates the spatial hepatic features in hepatocyte-like cells derived from human embryonic stem cells |
| Faiza Farhan, Imperial College London, UK | |
| 11:30-11:50 | Human placenta-derived mesenchymal stem cells stimulate neuronal regeneration by promoting axon growth and restoring neuronal activity |
| Maite Iglesias, Universidad Francisco de Vitoria, Spain | |
| 11:50-12:10 | Quantification of Human Hematopoietic Stem Cells in Immunodeficient Mice |
| Marcus Muench, Vitalant Research Institute, USA | |
| 12:10-12:30 | Ischemia and Reperfusion in Enhancing Myogenic Progenitor Cell Transplantation |
| Rainer Marksteiner, Co-founder and CSO of Innovacell AG, Austria | |
| 12:30-12:50 | iPSC as model systems to study disease progression in Myelodysplastic syndromes. |
| Paloma Garcia, University of Birmingham, United Kingdom | |
| 12:50-13:10 | Adipose-Derived Stem Cells to Treat Ischemic Diseases: Peripheral Artery Disease |
| Gemma Arderiu, Cardiovascular area, Institut de Recerca Sant Pau, Spain | |
| 13:10- 14:00 Lunch @ Restaurant | |
| 14:00-14:20 | The olfactory receptor Olfr78 promotes differentiation of enterochromaffin cells in the mouse colon |
| M.Isabelle Garcia, Universite libre de Bruxelles ULB, Belgium | |
| 14:20-14:40 | Common molecular mechanisms of SLC6A1 variant-mediated neurodevelopmental disorders in astrocytes and neurons |
| Jing-Qiong Kang, Vanderbilt University Medical Center, USA | |
| 14:40-15:00 | Subretinal Implantation of Human Primary RPE Cells Cultured on Nanofibrous Membranes in Minipigs |
| Hana Studenovska, Institute of Macromolecular Chemistry CAS, Czech Republic | |
| 15:00-15:20 | Progress on the Endometrium_ Update on Function, Pathology, and Testing |
| David Frankfurter, Yale Universtiy School of Medicine, USA | |
| 15:20-15:40 | Slot Available |
| 15:40- 16:00 Refreshment Break @ Foyer | |
| 16:00-16:20 | Role of Jag2 in HCC tumorigenesis |
| Liang Qiao, Westmead Institute for Medical Research, Australia | |
| 16:20-16:40 | Lipids Maintain Genomic Stability and Full Potency of Murine Embryonic Stem Cells |
| Duancheng Wen, Weill Cornell Medical College, USA | |
| 16:40-17:00 | Slot Available |
10:30-16:00
Day-2 Hall B
| Parallel Session | |
| DAY 2 Oct 08, 2024 HALL- B |
|
| 10:50-11:10 | Encapsulation of human-bone-marrow-derived mesenchymal stem cells in small alginate beads using one-step emulsification by internal gelation: evaluation in degenerate intervertebral disc model |
| Sarit Sivan, Braude College of Engineering, Israel | |
| 11:10-11:30 | Adult Prg4+ population is the principal progenitor for long-term articular cartilage wound repair in situ |
| Mei Massengale, Spaulding Rehabilitation Network at Mass General Brigham, USA | |
| 11:30-11:50 | BCG vaccine packaged human mesenchymal stem cells reprogram the transcriptome of naïve human macrophages ex vivo switching them into an M1 phenotype that controls the growth of Mycobacterium tuberculosis |
| Chinnaswamy Jagannath, Houston Methodist Research Institute, Weill Cornell Medicine, USA | |
| 11:50-12:10 | Muscling Towards Cell Therapy |
| Michael Hicks, University of California, Irvine, USA | |
| 12:10-12:30 | Slot Available |
| 12:30-12:50 | Identification of a Hematopoietic Cell Population Emerging From Mouse |
| Alexandrina Burlacu, Institute of Cellular Biology and Pathology “Nicolae Simionescu”, Romania | |
| 12:50-13:10 | CDK inhibitors, CYC065 and THZ1 induce apoptotic cell death in glioma stem cells in the in vitro and in vivo models of recurrent GBM |
| Brona M. Murphy, Centre for Systems Medicine, Royal College of Surgeons in Ireland, Ireland | |
| 13:10- 14:00 Lunch @ Restaurant | |
| 14:00-14:20 | Mesenchymal Stem Cells Derived Extracellular Vesicles Alleviate Traumatic Hemorrhagic Shock Induced Hepatic Injury via IL-10/PTPN22-Mediated M2 Kupffer Cell Polarization |
| Yunwei Zhang, Wuhan Union Hospital, China | |
| 14:20-14:40 | Slot Available |
| 14:40-15:00 | Slot Available |
| 15:00-15:20 | A look at a well-orchestrated wound healing response |
| Guluna ERDEM KOC, Gaziantep University, Turkey | |
| 15:20-15:40 | Slot Available |
| 15:40- 16:00 Refreshment Break @ Foyer | |
09:00-17:00
Day- 2 Parallel - Virtual Session CET- Berlin Time
| DAY 2 Oct 08, 2024 Parallel Virtual Session- CET- Berlin Time (**The slot timings will be adjusted based the time difference with Berlin time to your local working times as the event progresses) |
|
| 09:00-09:20 | Aquaporin-4 and Transient Receptor Potential Vanilloid 4 balance in early postnatal astrocyte differentiation |
| Antonio Cibelli, University of Bari Aldo Moro, Bari, Italy | |
| 09:20-09:40 | Long-term structural changes in the osteochondral unit in patients with osteoarthritis undergoing corrective osteotomy with PRP or SVF post-treatments |
| Elena Tchetina, Nasonova Research Institute of Rheumatology, Russia | |
| 09:40-10:00 | Why biomaterial implants and cellular therapy have not become a regular clinical reality yet? |
| Lindemberg M Silveira-Filho, Universidade Estadual de Campinas, Brazil | |
| 10:00-10:20 | Epigenetic Reprogramming Regulates Epithelial Progenitor Cell Signatures and Drives Inflammation in Hidradenitis Suppurativa |
| Lin Jin, University of Alabama at Birmingham, USA | |
| 10:20-10:40 | Protection of cell therapeutics from antibody-mediated killing by IgG Fc receptor overexpression |
| Tobias Deuse, UCSF, USA | |
| 10:40-11:00 | CTNS Mutation Alters Differentiation of Human-induced Pluripotent Stem Cells (hiPSCs) into Renal Proximal Tubules |
| Mary Taub, University at Buffalo, USA | |
| 11:00-11:20 | Selection for CD26− and CD49A+ Cells from Pluripotent Stem Cells-Derived Islet-Like Clusters Improves Therapeutic Activity in Diabetic Mice |
| Kfir Molakandov, Kadimastem Inc., Israel | |
| 11:20-11:40 | Ascorbic acid mitigates the impact of oxidative stress in a human model of febrile seizure and mesial temporal lobe epilepsy |
| Stefania Scalise, University degli Studi Magna Graecia, Italy | |
| 11:40-12:00 | Chemical Tracking Of Individual Epigenetic Writers During Cell State Transitions |
| Saulius Klimašauskas, Vilnius University Life Sciences Center, Lithuania | |
| 12:00-12:20 | Defining parallels between gliogenesis and gliomagenesis |
| Stacey Glasgow, University of California San Diego, USA | |
| 12:20-12:40 | Decrypting cell fate from a lens of intracellular pH dynamics |
| Yi Liu, University of California, San Francicsco, USA | |
| 12:40-13:00 | Printable Cellular Scaffold with Human iPSCs and IGF Regenerates Skeletal Muscle and Improves Functions following Muscle Injuries |
| Indranil Sinha, Brigham and Women's Hospital, USA | |
| 13:00-13:20 | MYSM1 Maintains the Expression of Ribosomal Protein Genes in Hematopoietic Stem Cells to Prevent Hematopoietic Dysfunction |
| Anastasia Nijnik, Department of Physiology, McGill University, Canada | |
| 13:20-13:40 | Mesenchymal Stem Cell Secretome in Ex-vivo Donor Heart Preservation |
| Meijing Wang, Indiana University School of Medicine, USA | |
| 13:40-14:00 | Pericardial effusion as a manifestation of graft versus host disease following allogeneic hematopoietic cell transplantation |
| Aasiya Matin, Division of Hematology, Mayo Clinic, USA | |
| 14:00-14:20 | Safety and Tolerability of Allogeneic Bone Marrow-Derived Mesenchymal Stem Cells for Parkinson’s Disease: Results from a Single-Center Phase Ia |
| Mya Schiess, McGovern Medical School at UTHealth Houston, USA | |
| 14:20-14:40 | Regulation of energy metabolism and skeletal muscle function by circulating peptide hormones |
| Katrin J Svensson, Stanford University, USA | |
| 14:40-15:00 | Slot Available |
| 15:00-15:20 | Slot Available |
| 15:20-15:40 | Slot Available |
| 15:40-16:00 | Slot Available |
| 16:00-16:20 | Slot Available |
| 16:20-16:40 | Slot Available |
| NOTE: We welcome interested candidates to submit the abstracts for available Slots and for Virtual presentations Contact Meeting Coordinator Dr. Edward John - john.e@stemcellcongress.org |
|